Evaluation of Neisseria gonorrhoeae Isolates Susceptibility to Tetracycline Antibiotics from 9 Provinces in China Since 2020

References

• Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat Rev Microbiol. 2018;16(4):226–240. doi:10.1038/nrmicro.2017.169
   PubMed Web of Science ®Google Scholar
• Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–562p. doi:10.2471/BLT.18.228486
   PubMed Web of Science ®Google Scholar
• Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis Primers. 2019;5(1):79. doi:10.1038/s41572-019-0128-6
   PubMed Web of Science ®Google Scholar
• Dong HV, Klausner JD. Neisseria gonorrhoeae resistance driven by antibiotic use. Nat Rev Urol. 2019;16(9):509–510. doi:10.1038/s41585-019-0206-2
   Web of Science ®Google Scholar
• Chen SC, Han Y, Yuan LF, Zhu XY, Yin YP. Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019;25(7):1427–1429. doi:10.3201/eid2507.190172
   PubMed Web of Science ®Google Scholar
• Williamson DA, Fairley CK, Howden BP, et al. Trends and risk factors for antimicrobial-resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018. Antimicrob Agents Chemother. 2019;63(10). doi:10.1128/AAC.01221-19
   Web of Science ®Google Scholar
• Seña AC, Bachmann L, Johnston C, et al. Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction. Lancet Infect Dis. 2020;20(8):e181–e191. doi:10.1016/S1473-3099(20)30171-7
   Web of Science ®Google Scholar
• Nelson ML, Levy SB. The history of the tetracyclines. Ann N Y Acad Sci. 2011;1241:17–32. doi:10.1111/j.1749-6632.2011.06354.x
   PubMed Web of Science ®Google Scholar
• Lee YR, Burton CE. Eravacycline, a newly approved fluorocycline. Eur J Clin Microbiol Infect Dis. 2019;38(10):1787–1794. doi:10.1007/s10096-019-03590-3
   PubMed Web of Science ®Google Scholar
• Dougherty JA, Sucher AJ, Chahine EB, Shihadeh KC. Omadacycline: a new tetracycline antibiotic. Ann Pharmacother. 2019;53(5):486–500. doi:10.1177/1060028018818094
   PubMed Web of Science ®Google Scholar
• Unemo M, Ballard R, Ison C, et al. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus; 2013.
   Google Scholar
• Wayne P Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing; 2011.
   Google Scholar
• Pfizer Inc. (Wyeth Pharmaceuticals). Tygacil® product insert. Philadelphia, PA. Available from: http://labeling.pfizer.com/showlabeling.aspx?id=491&pagename=tygacil_fly. Accessed March 18, 2022. 2016.
   Google Scholar
• Yang F, Yan J, Zhang J, van der Veen S. Evaluation of alternative antibiotics for susceptibility of gonococcal isolates from China. Int J Antimicrob Agents. 2020;55(2):105846. doi:10.1016/j.ijantimicag.2019.11.003
   Web of Science ®Google Scholar
• Dong Y, Yang Y, Wang Y, Martin I, Demczuk W, Gu W. Shanghai Neisseria gonorrhoeae isolates exhibit resistance to extended-spectrum cephalosporins and clonal distribution. Front Microbiol. 2020;11:580399. doi:10.3389/fmicb.2020.580399
   Web of Science ®Google Scholar
• Demczuk W, Sidhu S, Unemo M, et al. Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains. J Clin Microbiol. 2017;55(5):1454–1468. doi:10.1128/JCM.00100-17
   PubMed Web of Science ®Google Scholar
• Patel J, Weinstein M, Eliopoulos G, et al. M100 Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85–92. doi:10.1177/0956462412472837
   PubMed Web of Science ®Google Scholar
• Workowski KA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(Suppl 8):S759–762. doi:10.1093/cid/civ771
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587–613. doi:10.1128/CMR.00010-14
   PubMed Web of Science ®Google Scholar
• Buder S, Dudareva S, Jansen K, et al. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC Infect Dis. 2018;18(1):44. doi:10.1186/s12879-018-2944-9
   Web of Science ®Google Scholar
• Yin YP, Han Y, Dai XQ, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15(2):e1002499. doi:10.1371/journal.pmed.1002499
   PubMed Web of Science ®Google Scholar
• Xu WQ, Zheng XL, Liu JW, et al. Antimicrobial susceptibility of ertapenem in Neisseria gonorrhoeae isolates collected within the China Gonococcal Resistance Surveillance Programme (China-GRSP) 2018. Infect Drug Resist. 2021;14:4183–4189. doi:10.2147/IDR.S335252
   Web of Science ®Google Scholar
• Wind CM, de Vries HJ, van Dam AP. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution. Int J Antimicrob Agents. 2015;45(3):305–308. doi:10.1016/j.ijantimicag.2014.10.020
   Web of Science ®Google Scholar
• Zhou Q, Liu J, Chen S, Xu W, Han Y, Yin Y. The accuracy of molecular detection targeting the mutation C2611T for detecting moderate-level azithromycin resistance in Neisseria gonorrhoeae: a systematic review and meta-analysis. Antibiotics (Basel, Switzerland). 2021;10(9):1027.
   Web of Science ®Google Scholar
• Wang F, Liu J, Liu H, et al. Evaluation of the accuracy of molecular assays targeting the mutation A2059G for detecting high-level azithromycin resistance in Neisseria gonorrhoeae: a systematic review and meta-analysis. Infect Drug Resist. 2019;12:95–104. doi:10.2147/IDR.S183754
   PubMed Web of Science ®Google Scholar
• Lagacé-Wiens PRS, Adam HJ, Laing NM, et al. Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential. J Antimicrob Chemother. 2017;72(8):2273–2277. doi:10.1093/jac/dkx147
   Web of Science ®Google Scholar
• Terreni M, Taccani M, Pregnolato M. New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives. Molecules (Basel, Switzerland). 2021;26(9):2671. doi:10.3390/molecules26092671
   PubMed Web of Science ®Google Scholar
• Eljaaly K, Ortwine JK, Shaikhomer M, Almangour TA, Bassetti M. Efficacy and safety of eravacycline: a meta-analysis. J Glob Antimicrob Resist. 2021;24:424–428. doi:10.1016/j.jgar.2021.02.009
   PubMed Web of Science ®Google Scholar
• Xiao M, Huang JJ, Zhang G, et al. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study. BMC Microbiol. 2020;20(1):350. doi:10.1186/s12866-020-02019-8
   PubMed Web of Science ®Google Scholar
• Zhanel GG, Esquivel J, Zelenitsky S, et al. Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent. Drugs. 2020;80(3):285–313. doi:10.1007/s40265-020-01257-4
   PubMed Web of Science ®Google Scholar
• Rodvold KA, Burgos RM, Tan X, Pai MP. Omadacycline: a review of the clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2020;59(4):409–425. doi:10.1007/s40262-019-00843-4
   PubMed Web of Science ®Google Scholar